Product Information

AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3075 per EA under NDC 31722044890. Its NADAC has been published 46 times since Jan 7, 2026.

FDA first approved this application on Feb 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMLODIPINE-OLMESARTAN 10-40 MG

Amlodipine and Olmesartan Medoxomil
$0.3075per EA
Low Outlier

Strength

10; 40 mg/1; mg/1

NDC

31722044890

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209591

FDA Approved

2/14/2025

TE Code

AB

On Market Since

2/14/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 46 times since Jan 7, 2026, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3075 per EA
All-time high$0.3615 (Mar 11, 2026)
All-time low$0.2982 (Oct 21, 2026)
52-week high$0.3615
52-week low$0.2982
Median price$0.3410
Average price$0.3345
Largest weekly change-5.5% (Sep 23, 2026)
Weeks tracked46
Tracking sinceJan 7, 2026

Price History

1W

+3.1%

1M

+3.1%

3M

-2.7%

6M

-9.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-9.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Camber Pharmaceuticals Inc., is $0.3075 per EA (NDC 31722044890), effective Nov 18, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 9.8%. It has been tracked across 46 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?

Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2982 (Oct 21, 2026) to a high of $0.3615 (Mar 11, 2026), with a median of $0.3410 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-40 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?

AMLODIPINE-OLMESARTAN 10-40 MG (NDC 31722044890) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.